Screener
Zentalis Pharmaceuticals, Inc. ZNTL Q1 2026 earnings
Reported May 12, 2026 · Before market open
EPS-$0.50Miss by $0.01
EPS estimate-$0.49
Next report
Nov 10, 2026 (in 2 months)EPS estimate-$0.61
Versus estimates
Diluted EPS
FAQ
- When did Zentalis Pharmaceuticals, Inc. report Q1 2026 earnings?
- Zentalis Pharmaceuticals, Inc. (ZNTL) reported Q1 2026 earnings on May 12, 2026 before market open.
- What were Zentalis Pharmaceuticals, Inc.'s Q1 2026 revenue and EPS?
- Zentalis Pharmaceuticals, Inc. reported eps of $-0.50 for Q1 2026.
- Did Zentalis Pharmaceuticals, Inc. beat estimates in Q1 2026?
- EPS missed the consensus estimate of $-0.49 by $0.01.
- How did Zentalis Pharmaceuticals, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 25.4% from $-0.67.
- Where can I find Zentalis Pharmaceuticals, Inc.'s Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001725160-26-000041) and the 10-Q periodic report (0001725160-26-000042) directly on SEC EDGAR. The filing index links above go to sec.gov.
